LD-2 disclosure · 2nd Quarter - Report
NOVARTIS
Client
- Name
- NOVARTIS
- Description
- Multinational biopharmaceutical company
- Location
- District of Columbia · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
LobbyistsZACHARY PFISTER · EMILY FELDER · ADAM STEINMETZ · ANDREW USYK · DEEMA TARAZI · mr JOHN REISING · STEPHEN HOLLAND
Covered position (mr JOHN REISING): Scheduler, Operations Director, Member Services Director, Deputy Chief of Staff- Majority Leader Steve Scalise; Operations Director, Rep. Bill Flores; Scheduler, Rep. Austin Scott; Intern, Senator Trent Lott.
TargetedHOUSE OF REPRESENTATIVES · U.S. Trade Representative (USTR)